Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Stem Cell Market Outlook

The global stem cell market size was valued at USD 19.41 billion in 2023, driven by the rising prevalence of various non-communicable diseases, the increasing investments in stem cell therapies, and the growing utilization of human-induced pluripotent stem cells (iPSCs). The market is anticipated to grow at a CAGR of 10.3% during the forecast period of 2024-2032 to achieve a value of USD 46.91 billion by 2032.

Global Stem Cell Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Prevalence of Regenerative Medicines Boosting the Market Growth of Stem Cell

The increasing activities to use stem cells in regenerative medicines owing to their therapeutic properties are augmenting the growth of the stem cell industry. The growing utilisation of human-induced pluripotent stem cells (iPSCs) for the treatment of various inherited heart complications, neurological disorders, and genetic diseases like recessive dystrophic epidermolysis bullosa (RBED) is significantly contributing to the market growth. Moreover, human-induced pluripotent stem cells (iPSCs) can eliminate immunosuppression, due to which they function as a significant source of cells for autologic stem cell therapy, therefore bolstering the industry growth. In addition, the increasing incentives provided by the leading companies to deliver breakthrough therapy for stem cells to surge the utilisation of advanced resources and tools in research and development activities (R&D) is providing impetus to the market growth of stem cell.

North America to Hold a Significant Share of the Stem Cell Industry

North America accounts for a considerable share of the overall stem cell industry owing to the increasing research and development (R&D) in the United States and Canada. Moreover, the rising prevalence of non-communicable chronic diseases, such as cancer and Parkinson’s, among others, is surging the deployment of stem cell treatment, which is strengthening the industry growth. Moreover, the robust healthcare sector in the region is increasing the accessibility for advanced cell therapy treatments, hence aiding the growth of the regional stem cell industry. Apart from this, the Asia Pacific region is expected to grow rapidly due to the rising use of regenerative medicines. Moreover, surging clinical trials owing to cheap labour costs and the availability of raw materials in the region is aiding the market growth, therefore significantly contributing to the overall industry growth.

Stem Cell: Market Segmentation

A stem cell is a cell that can develop various cells ranging from brain cells to muscle cells. It can also aid in fixing damaged tissues. As stem cells have the potential to treat various non-communicable and chronic diseases, such as Alzheimer’s and diabetes, among others, they are employed in various medical and biotechnological research activities to repair tissue damage caused by diseases.

Global Stem Cell Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The major product types of stem cell are:

  • Adult Stem Cell
  • Human Embryonic Cell
  • Pluripotent Stem Cell
  • Others

The market can be broadly categorised on the basis of its treatment types into:

  • Allogeneic Stem Cell Therapy 
  • Autologic Stem Cell Therapy
  • Syngeneic Stem Cell Therapy

Based on applications, the market is divided into:

  • Neurological Disorders 
  • Orthopaedic Treatments
  • Oncology Disorders
  • Injuries and Wounds
  • Cardiovascular Disorders
  • Others

The EMR report looks into the regional markets of stem cell like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Global Stem Cell Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Technological Advancements to Bolster the Market Growth of Stem Cell

Increasing research activities in regenerative medicines and biotechnology to personalise stem cell therapy is anticipated to propel the market growth. The rising demand for treatment of prevalent issues, such as age-related macular degeneration (AMD), among the growing geriatric population is expected to increase the use of stem cells. As each cell posits individual characteristics, it becomes very difficult to characterise cell products due to various error bars during research activities. This is consequently surging the integration of the latest technologies, such as artificial intelligence (AI), blockchain, and machine learning. The use of artificial intelligence (AI) to rapidly analyse images, predict cell functions, and classify tissues to identify cell products, which is estimated to augment the market growth.

The increasing prevalence of cancer and cancer-related research projects is increasing the use of blockchain technology to collect and assimilate data to enhance the accessibility to clinical results and the latest developments. Blockchain can also aid in storing patients’ data efficiently while enhancing the cost-effectiveness of cord-blood banking for advanced research and development (R&D) activities. Moreover, the integration of machine learning algorithms to analyse images and infer the correlation between cellular structures is bolstering the market growth. The growing interest in comprehending processes at a cellular level and identify crucial processes using deep learning is projected to propel the growth of the stem cell industry.

Key Industry Players in the Global Stem Cell Market

The report presents a detailed analysis of the following key players in the global stem cell market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Pluristem Therapeutics Inc.
  • Thermo Fisher Scientific Inc.
  • Cellular Engineering Technologies
  • Merck KGaA
  • Becton, Dickinson and Company
  • STEMCELL Technologies Inc.
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Application
  • End User
  • Region
Breakup by Type
  • Adult Stem Cells (ASCs)
  • Human Embryonic Stem Cells (HESCs)
  • Induced Pluripotent Stem Cells (iPSCs)
  • Very Small Embryonic Like Stem Cells
Breakup by Application
  • Regenerative Medicine
  • Drug Discovery and Development
Breakup by End User
  • Hospitals and Surgical Centers
  • Therapeutic Companies
  • Services Companies
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Athersys Inc.
  • Mesoblast Ltd.
  • Biorestorative Therapies Inc.
  • Pluristem Inc.
  • Brainstorm Cell Limited.
  • ViaCyte Inc.
  • Gamida Cell
  • HOPE BIOSCIENCES
  • Cellular Biomedicine Group
  • Smith+Nephew
  • MEDIPOST
  • ANTEROGEN. C.O., LTD.
  • NuVasive Inc.
  • RTI Surgical
  • AlloSource
  • JCR Pharmaceuticals Co. Ltd.
  • Takeda Pharmaceutical Company Limited
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

Stem Cell Market Report Snapshots

Stem Cell Market Size

Stem Cell Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

In 2023, the global market for stem cell attained a value of USD 19.41 billion.

The market is anticipated to grow at a CAGR of 10.3% during the forecast period of 2024-2032 to reach a value of USD 46.91 billion by 2032.

The market is being aided by the rising prevalence of various non-communicable diseases, the increasing investments in stem cell therapies, and the growing utilisation of human-induced pluripotent stem cells (iPSCs).

The market is expected to be driven by the increasing research activities in regenerative medicines, the treatment of various health-related issues through cell therapy, and the integration of the latest technologies in research and development (R&D) activities.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major product types of stem cell in the industry are adult stem cell, human embryonic cell, and pluripotent stem cell, among others.

The significant treatment types in the market are allogeneic stem cell therapy, autologic stem cell therapy, and syngeneic stem cell therapy.

The various applications of stem cell are neurological disorders, orthopaedic treatments, oncology disorders, injuries and wounds, and cardiovascular disorders, among others.

The major players in the industry are Pluristem Therapeutics Inc., Thermo Fisher Scientific Inc., Cellular Engineering Technologies, Merck KGaA, Becton, Dickinson and Company, and STEMCELL Technologies Inc., among others.

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Pricing Plans

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Strategic Solutions for Informed Decision-Making

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124